Results 41 to 50 of about 22,419 (100)

The Examination of the Escape Phenomenon of the Disease Modifying Antirheumatic Drugs

, 2005
Yoichi Kawasaki, Masahiro Moriyama, Kazuhiko Shibata, Yutaka Gomita   +3 more
openalex   +2 more sources

Adherence to the antirheumatic drugs: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Aksoy N, Ozturk N, Agh T, Kardas P.
europepmc   +1 more source

Time to Disease-modifying Antirheumatic Drug Treatment in Rheumatoid Arthritis and Its Predictors: A National, Multicenter, Retrospective Cohort [PDF]

, 2012
Ruben Tavares, Janet Pope, JEAN-LUC TREMBLAY, CARTER THORNE, VIVIAN P. BYKERK, JURIS LAZOVSKIS, KENNETH L.N. BLOCKA, MARY J. BELL, Diane Lacaille, Carol Hitchon, AVRIL A. FITZGERALD, WESLEY K. FIDLER, ARTHUR A.M. BOOKMAN, JAMES M. HENDERSON, DIANNE P. MOSHER, DALTON E. SHOLTER, Majed Khraishi, Boulos Haraoui, HONG CHEN, XIUYING LI, Andreas Laupacis, Gilles Boire, George Tomlinson, Claire Bombardier   +23 more
openalex   +1 more source

Biological Disease-Modifying Antirheumatic Drugs Decrease Uric Acid Levels in the Sera of Patients with Psoriatic Arthritis. [PDF]

Curr Issues Mol Biol
Perković D, Petrić M, Maleš M, Erceg Maleš I, Radić M.   +4 more
europepmc   +1 more source

Personalized dose reduction strategies for biologic disease-modifying antirheumatic drugs for treating axial spondyloarthritis: a clinical and economic evaluation with predictive modeling. [PDF]

BMC Rheumatol
Binh BH, Phuong NTT, Hang VTT, Nhan NTT, Hoa NTN, Van Dung H.   +5 more
europepmc   +1 more source

Monotreatment With Conventional Antirheumatic Drugs or Glucocorticoids in Rheumatoid Arthritis: A Network Meta-Analysis.

JAMA Netw Open, 2023
Guski LS, Jürgens G, Pedder H, Levinsen NKG, Andersen SE, Welton NJ, Graudal N.   +6 more
europepmc   +1 more source

Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment [PDF]

, 2014
Annelieke Pasma, Adriaan van ’t Spijker, Jolanda J. Luime, Margot Walter, Jan J.V. Busschbach, Johanna M W Hazes   +5 more
openalex   +1 more source

Joint Damage Progression in Patients with Rheumatoid Arthritis in Clinical Remission. Do Biologics Perform Better Than Synthetic Antirheumatic Drugs? [PDF]

, 2014
Elena Ciubotariu, Cem Gabay, Axel Finckh
openalex   +1 more source

Abatacept, Golimumab, and Sarilumab as Selected Bio-Originator Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action in Their Current Use in Treatment. [PDF]

J Clin Med
Kawczak P, Feszak IJ, Bączek T.
europepmc   +1 more source

Factors Associated With The Initiation Of Biologic Disease Modifying Antirheumatic Drugs In Texas Medicaid Patients With Rheumatoid Arthritis [PDF]

, 2014
G. Kim, Jamie C. Barner, KL Rascati, Kristin M. Richards   +3 more
openalex   +1 more source